RedHill Biopharma (RDHL) Research & Development (2012 - 2023)
RedHill Biopharma (RDHL) posted Research & Development of $2.02 million for the year ended Dec 31, 2025, up 27.4% from $1.59 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Research & Development (2012 - 2023) Analysis & Trends
Since the year ended Dec 31, 2009, RedHill Biopharma has reported Research & Development for 17 years.
- Annual Research & Development shows a five-year compound annual growth rate of -34.3% (years ended Dec 2020 to Dec 2025).
- Annual Research & Development has run from a low of $1.59 million in the year ended Dec 31, 2024 to a high of $29.5 million in the year ended Dec 31, 2021 over five years.
- Business Quant data shows RDHL's Research & Development at $1.59 million in the year ended Dec 31, 2024 (-55.0%), $3.53 million in the year ended Dec 31, 2023 (-51.5%), $7.28 million in the year ended Dec 31, 2022 (-75.3%) and $29.5 million in the year ended Dec 31, 2021 (+78.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.33 Bn | 1,106.91 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 618.82 Bn | 537.35 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 503.36 Bn | 476.47 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 369.59 Bn | 323.96 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 298.57 Bn | 262.56 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.25 Bn | 234.94 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 237.35 Bn | 192.75 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 191.27 Bn | 165.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 170.03 Bn | 116.68 Bn | 10.94 Bn | 2.81 Bn |
| 10 | RedHill Biopharma | 1.45 Mn | -15.16 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 1.25 Mn |
| Mar 31, 2023 | 1.08 Mn |
| Dec 31, 2022 | 1.13 Mn |
| Sep 30, 2022 | 1.61 Mn |
| Jun 30, 2022 | 1.47 Mn |
| Mar 31, 2022 | 3.06 Mn |
| Dec 31, 2021 | 5.87 Mn |
| Sep 30, 2021 | 5.82 Mn |
| Jun 30, 2021 | 10.33 Mn |
| Mar 31, 2021 | 7.48 Mn |
| Dec 31, 2020 | 6.19 Mn |
| Sep 30, 2020 | 4.32 Mn |
| Jun 30, 2020 | 3.21 Mn |
| Mar 31, 2020 | 2.77 Mn |
| Dec 31, 2019 | 2.28 Mn |
| Sep 30, 2019 | 2.80 Mn |
| Jun 30, 2019 | 6.97 Mn |
| Mar 31, 2019 | 5.37 Mn |
| Dec 31, 2018 | 5.78 Mn |
| Sep 30, 2018 | 6.62 Mn |
API Access
RedHill Biopharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();